ロード中...
Reading between the lines; understanding drug response in the post genomic era
Following the fanfare of initial, often dramatic, success with small molecule inhibitors in the treatment of defined genomic subgroups, it can be argued that the extension of targeted therapeutics to the majority of patients with solid cancers has stalled. Despite encouraging FDA approval rates, the...
保存先:
| 出版年: | Mol Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528621/ https://ncbi.nlm.nih.gov/pubmed/24957465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.05.014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|